Guido Neels

EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN.

Oraya Therapeutics, Inc. develops and commercializes a non-invasive therapy for wet age-related macular degeneration. The firm delivers a precise dose of radiation non-invasively to the macula using an automated positioning system and a localizing algorithm. The company was founded by Michael E. Gertner in 2006 and is headquartered in Newark, CA.

Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA.

Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

White Pine Medical, Inc. manufactures and markets medical devices. The company was founded in February 2010 and is headquartered in Park City, UT.

ROX Medical, Inc. manufactures medical ultrasonic scanning devices. It offers ROX Coupler that is intended for use in patients with treatment resistant hypertension to lower blood pressure by reducing peripheral vascular resistance and improving vascular compliance; and in patients with chronic obstructive pulmonary disease to improve breathing, reduce symptoms of chronic bronchitis, and improve exercise tolerance. The company was founded by Rodney Brenneman and John Faul in 2004 and is headquartered in San Clemente, CA.

Entellus Medical, Inc. is a medical technology company, which engages in the design, development, and commercialization of treatment of chronic and recurrent sinusitis in both adult and pediatric patients. The company was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Saint Paul, MN.

Christel House International, Inc. provides child care services. They help children break the cycle of poverty, realize their hopes and dreams, and become self-sufficient, contributing members of their societies. The company was established in 1998 by Christel DeHaan and is headquartered in Indianapolis, IN.

Bioventus LLC is a holding company, which manufactures medical equipment. It develops bone healing devices and distributes osteoarthritis injection therapies. Its products include ultrasound bone healing device, joint therapies, and osteoarthritis injection therapies. The company was founded in 2012 and is headquartered in Durham, NC.

Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX.

EW Healthcare Partners Fund seeks investment opportunities in middle market companies located in the United States, Europe, Latin America, and China with revenues of USD 20 to USD 200 million. It targets companies operating in the fields of pharmaceuticals, medical devices, healthcare services, and healthcare IT. It provides financing for growth capital requirements with an investment size ranging from USD 20 to USD 80 million and invest up to USD 100 million. It also acquires minority and majority interest.